With more than 20 approved HIV antiretrovirals in the United States, physicians have many options for their patients -- they can choose one of the "preferred" drug regimens or deviate from treatment guidelines entirely.
A new study finds significant health disparities between black and white men with HIV, even though these men had equal access to health care through the Veterans Administration (VA).
Women with HIV should receive not only the same antiretroviral therapy as men, but also clinical care tailored to their specific risk factors and health care goals, according to Kathleen Squires, M.D.
Researchers at IDWeek 2015 discussed the logistics of delivering antiretroviral therapy to all 37 million people living with HIV in the world and how to reach people during acute HIV infection.
What are the hottest developments in HIV clinical science over the past year? Physician-researcher Adaora Adimora, M.D., M.P.H., brought us a brief tour of key highlights at the start of the IDWeek 2015 medical conference in San Diego.
Each year we see new developments in HIV that improve the lives of those living with the disease and make it easier for providers to care for patients. We asked some of the leading experts what development this year they thought would have the biggest …
HIV treatment remains far from perfect, and there are still seats at the table available for improved antiretrovirals. Paul Sax, M.D., provides an update on several of the most noteworthy candidates currently in development.
Here’s a recap of the biggest developments in HIV treatment over the past year, as well as a look at what’s to come.
A new study finds that black people are less likely to keep their viral load down on Atripla -- and that more trouble with side effects may be the reason.
A single drug dose, taken no more than once a month, to treat HIV: It's no longer the stuff of idle fantasy. But in a world stuffed with excellent once-a-day drugs, will long-acting meds have value?